urovestВестник урологииUrology Herald2308-6424Rostov State Medical University10.21886/2308-6424-2023-11-2-144-153urovest-729Research ArticleОБЗОРЫ ЛИТЕРАТУРЫREVIEWS ARTICLEПенильная реабилитация у пациентов после оперативного лечения болезни ПейрониPenile rehabilitation in patients following surgical treatment of Peyronie’s diseasehttps://orcid.org/0000-0003-3764-6131КотовС. В.KotovS. V.

Сергей Владиславович Котов — доктор медицинских наук, профессор; заведующий кафедрой урологии и андрологии ФГАОУ ВО РНИМУ им. Н.И. Пирогова Минздрава России; руководитель Университетской клинки урологии, онкоурологии и андрологии ГБУЗ «ММКЦ «Коммунарка» ДЗМ»; врач-уролог урологического отделения ГБУЗ «ГКБ № 1 им. Н.И. Пирогова ДЗМ».

Москва

Sergey V. Kotov — M.D., Dr.Sc. (Med), Full Prof.; Head, Dept. of Urology and Andrology, Pirogov Russian National Research Medical University (Pirogov Medical University); Head, University Clinic of Urology, Oncourology and Andrology, «Kommunarka» Moscow Multidisciplinary Clinical Centre; Urologist, Urology Division, Pirogov City Clinical Hospital No.1.

Moscow

urokotov@mail.ruhttps://orcid.org/0000-0001-8202-3844ЮсуфовА. Г.YusufovA. G.

Анвар Гаджиевич Юсуфов — кандидат медицинских наук; доцент кафедры урологии и андрологии ФГАОУ ВО РНИМУ им. Н.И. Пирогова Минздрава России; заведующий урологическим отделением ГБУЗ «ММКЦ «Коммунарка» ДЗМ».

Москва

Anvar G. Yusufov — M.D., Cand.Sc.(Med); Assoc.Prof., Dept. of Urology and Andrology, Pirogov Russian National Research Medical University (Pirogov Medical University); Head, Urology Division, «Kommunarka» Moscow Multidisciplinary Clinical Centre.

Moscow

anvar.yusufov@mail.ruhttps://orcid.org/0000-0001-9091-8189СоколовН. М.SokolovN. M.

Никита Михайлович Соколов — аспирант кафедры урологии и андрологии ФГАОУ ВО РНИМУ им. Н.И. Пирогова Минздрава России

Москва

Nikita M. Sokolov — M.D.; Postgrad. Student, Dept. of Urology and Andrology, Pirogov Russian National Research Medical University (Pirogov Medical University).

Moscow

4eaman@gmail.comhttps://orcid.org/0000-0002-7374-7020МаммаевР. У.MammaevR. U.

Рамазан Умаханович Маммаев — ординатор кафедры урологии и андрологии ФГАОУ ВО РНИМУ им. Н.И. Пирогова Минздрава России.

Москва

Ramazan U. Mammaev — Resident, Dept. of Urology and Andrology, Pirogov Russian National Research Medical University (Pirogov Medical University).

Moscow

ramazan.mammaev@outlook.comРоссийский национальный исследовательский медицинский университет им. Н.И. Пирогова; Московский многопрофильный клинический центр «Коммунарка»; Городская клиническая больница №1 им. Н.И. ПироговаРоссияPirogov Russian National Research Medical University (Pirogov Medical University); «Kommunarka» Moscow Multidisciplinary Clinical Centre; Pirogov City Clinical Hospital No.1Russian FederationРоссийский национальный исследовательский медицинский университет им. Н.И. Пирогова; Московский многопрофильный клинический центр «Коммунарка»РоссияPirogov Russian National Research Medical University (Pirogov Medical University); «Kommunarka» Moscow Multidisciplinary Clinical CentreRussian FederationРоссийский национальный исследовательский медицинский университет им. Н.И. ПироговаРоссияPirogov Russian National Research Medical University (Pirogov Medical University)Russian Federation202319072023112144153Copyright © Котов С.В., Юсуфов А.Г., Соколов Н.М., Маммаев Р.У., 20232023Котов С.В., Юсуфов А.Г., Соколов Н.М., Маммаев Р.У.Kotov S.V., Yusufov A.G., Sokolov N.M., Mammaev R.U.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.urovest.ru/jour/article/view/729

Болезнь Пейрони (БП) — приобретённое заболевание, в основе которого лежит нарушение процесса заживления ран, результатом которого является формирование фиброзных бляшек в белочной оболочке кавернозных тел. Распространённость эректильной дисфункции среди пациентов с БП по данным различных исследований варьирует от 22% до 54%. «Золотым стандартом» коррекции искривления полового члена при БП по настоящее время остаётся хирургическое лечение. Важно отметить, что существующие методы оперативного лечения БП (методики с укорочением или удлинением белочной оболочки) несут в себе риски развития эректильной дисфункции или же усугубления её тяжести. В то же время отсутствие адекватной сексуальной реабилитации после оперативного лечения БП сопряжено со значимым ухудшением функциональных результатов. В связи с вышеизложенным целью данной статьи стала систематизация информации по методам пенильной реабилитации пациентов после хирургического лечения БП, которая показала, что данная проблема остаётся актуальной по настоящий день. Большинство существующих методов пенильной реабилитации в настоящий момент недостаточно изучены, в связи с чем нельзя дать однозначных рекомендаций по поводу использования того или иного метода. Обращает на себя внимание малое количество хорошо спланированных, рандомизированных исследований по данной проблеме, что, вероятнее всего, обусловлено относительной редкостью заболевания.

Peyronie's disease (PD) is an acquired disease, which is based on a violation of the wound healing process, which results in the formation of fibrous plaques in the tunica albuginea of the cavernous bodies. The prevalence of erectile dysfunction (ED) among patients with PD ranges from 22% to 54%, according to various studies. Surgical treatment remains the "gold standard" for correcting penile curvature in PD. It is important to note that the existing methods of PD surgery (techniques with shortening or lengthening of the tunica albuginea) carry the risks of developing ED or aggravating its severity. At the same time, the absence of adequate sexual rehabilitation following PD surgery is associated with a significant deterioration in functional outcomes. In view of the above, the article is aimed to systematise information on penile rehabilitation methods in patients following PD surgery, which showed that the problem remains relevant to the present day. Most existing penile rehabilitation methods are currently not sufficiently investigated, and it is therefore impossible to give clear recommendations on the use of any method. The small number of well-designed and randomised studies on this problem is noteworthy, most likely due to the relative rarity of the disease.

пенильная реабилитациясексуальная реабилитацияэректильная дисфункцияболезнь Пейрониpenile rehabilitationsexual rehabilitationerectile dysfunctionPeyronie's diseaseИсследование не имело спонсорской поддержкиThe study was not sponsoredReferencesZiegelmann MJ, Bajic P, Levine LA. Peyronie's disease: Contemporary evaluation and management. Int J Urol. 2020;27(6):504-516. DOI: 10.1111/iju.14230Ziegelmann MJ, Bajic P, Levine LA. Peyronie's disease: Contemporary evaluation and management. Int J Urol. 2020;27(6):504-516. DOI: 10.1111/iju.14230Schwarzer U, Sommer F, Klotz T, Braun M, Reifenrath B, Engelmann U. The prevalence of Peyronie's disease: results of a large survey. BJU Int. 2001;88(7):727-30. DOI: 10.1046/j.1464-4096.2001.02436.xSchwarzer U, Sommer F, Klotz T, Braun M, Reifenrath B, Engelmann U. The prevalence of Peyronie's disease: results of a large survey. BJU Int. 2001;88(7):727-30. DOI: 10.1046/j.1464-4096.2001.02436.xKadioglu A, Sanli O, Akman T, Canguven O, Aydin M, Akbulut F, Kucukdurmaz F. Factors affecting the degree of penile deformity in Peyronie disease: an analysis of 1001 patients. J Androl. 2011;32(5):502-8. DOI: 10.2164/jandrol.110.011031Kadioglu A, Sanli O, Akman T, Canguven O, Aydin M, Akbulut F, Kucukdurmaz F. Factors affecting the degree of penile deformity in Peyronie disease: an analysis of 1001 patients. J Androl. 2011;32(5):502-8. DOI: 10.2164/jandrol.110.011031Kadioglu A, Tefekli A, Erol B, Oktar T, Tunc M, Tellaloglu S. A retrospective review of 307 men with Peyronie's disease. J Urol. 2002;168(3):1075-9. DOI: 10.1016/S0022-5347(05)64578-8Kadioglu A, Tefekli A, Erol B, Oktar T, Tunc M, Tellaloglu S. A retrospective review of 307 men with Peyronie's disease. J Urol. 2002;168(3):1075-9. DOI: 10.1016/S0022-5347(05)64578-8Smith JF, Walsh TJ, Conti SL, Turek P, Lue T. Risk factors for emotional and relationship problems in Peyronie's disease. J Sex Med. 2008;5(9):2179-84. DOI: 10.1111/j.1743-6109.2008.00949.xSmith JF, Walsh TJ, Conti SL, Turek P, Lue T. Risk factors for emotional and relationship problems in Peyronie's disease. J Sex Med. 2008;5(9):2179-84. DOI: 10.1111/j.1743-6109.2008.00949.xNelson CJ, Diblasio C, Kendirci M, Hellstrom W, Guhring P, Mulhall JP. The chronology of depression and distress in men with Peyronie's disease. J Sex Med. 2008;5(8):1985-90. DOI: 10.1111/j.1743-6109.2008.00895.xNelson CJ, Diblasio C, Kendirci M, Hellstrom W, Guhring P, Mulhall JP. The chronology of depression and distress in men with Peyronie's disease. J Sex Med. 2008;5(8):1985-90. DOI: 10.1111/j.1743-6109.2008.00895.xChung E, Ralph D, Kagioglu A, Garaffa G, Shamsodini A, Bivalacqua T, Glina S, Hakim L, Sadeghi-Nejad H, Broderick G. Evidence-Based Management Guidelines on Peyronie's Disease. J Sex Med. 2016;13(6):905-23. DOI: 10.1016/j.jsxm.2016.04.062Chung E, Ralph D, Kagioglu A, Garaffa G, Shamsodini A, Bivalacqua T, Glina S, Hakim L, Sadeghi-Nejad H, Broderick G. Evidence-Based Management Guidelines on Peyronie's Disease. J Sex Med. 2016;13(6):905-23. DOI: 10.1016/j.jsxm.2016.04.062Montague DK. Peyronie disease and erectile dysfunction: A potential new paradigm. Cleve Clin J Med. 2021;88(12):661-663. DOI: 10.3949/ccjm.88a.21027Montague DK. Peyronie disease and erectile dysfunction: A potential new paradigm. Cleve Clin J Med. 2021;88(12):661-663. DOI: 10.3949/ccjm.88a.21027Campbell J, Alzubaidi R. Understanding the cellular basis and pathophysiology of Peyronie's disease to optimize treatment for erectile dysfunction. Transl Androl Urol. 2017;6(1):46-59. DOI: 10.21037/tau.2016.11.01Campbell J, Alzubaidi R. Understanding the cellular basis and pathophysiology of Peyronie's disease to optimize treatment for erectile dysfunction. Transl Androl Urol. 2017;6(1):46-59. DOI: 10.21037/tau.2016.11.01Sansalone S, Garaffa G, Djinovic R, Pecoraro S, Silvani M, Barbagli G, Zucchi A, Vespasiani G, Loreto C. Long-term results of the surgical treatment of Peyronie's disease with Egydio's technique: a European multicentre study. Asian J Androl. 2011;13(6):842-5. DOI: 10.1038/aja.2011.42Sansalone S, Garaffa G, Djinovic R, Pecoraro S, Silvani M, Barbagli G, Zucchi A, Vespasiani G, Loreto C. Long-term results of the surgical treatment of Peyronie's disease with Egydio's technique: a European multicentre study. Asian J Androl. 2011;13(6):842-5. DOI: 10.1038/aja.2011.42Hakky TS, Baumgarten AS, Parker J, Zheng Y, Kongnyuy M, Martinez D, Carrion RE. Penile rehabilitation: the evolutionary concept in the management of erectile dysfunction. Curr Urol Rep. 2014;15(4):393. DOI: 10.1007/s11934-014-0393-6Hakky TS, Baumgarten AS, Parker J, Zheng Y, Kongnyuy M, Martinez D, Carrion RE. Penile rehabilitation: the evolutionary concept in the management of erectile dysfunction. Curr Urol Rep. 2014;15(4):393. DOI: 10.1007/s11934-014-0393-6Kuthe A. Phosphodiesterase 5 inhibitors in male sexual dysfunction. Curr Opin Urol. 2003;13:405-410. DOI: 10.1097/01.mou.0000088747.16181.4bKuthe A. Phosphodiesterase 5 inhibitors in male sexual dysfunction. Curr Opin Urol. 2003;13:405-410. DOI: 10.1097/01.mou.0000088747.16181.4bAlwaal A, Al-Mannie R, Carrier S. Future prospects in the treatment of erectile dysfunction: focus on avanafil. Drug Des Devel Ther. 2011;5:435-43. DOI: 10.2147/DDDT.S15852Alwaal A, Al-Mannie R, Carrier S. Future prospects in the treatment of erectile dysfunction: focus on avanafil. Drug Des Devel Ther. 2011;5:435-43. DOI: 10.2147/DDDT.S15852Valente EG, Vernet D, Ferrini MG, Qian A, Rajfer J, Gonzalez-Cadavid NF. L-arginine and phosphodiesterase (PDE) inhibitors counteract fibrosis in the Peyronie's fibrotic plaque and related fibroblast cultures. Nitric Oxide. 2003;9(4):229-44. DOI: 10.1016/j.niox.2003.12.002Valente EG, Vernet D, Ferrini MG, Qian A, Rajfer J, Gonzalez-Cadavid NF. L-arginine and phosphodiesterase (PDE) inhibitors counteract fibrosis in the Peyronie's fibrotic plaque and related fibroblast cultures. Nitric Oxide. 2003;9(4):229-44. DOI: 10.1016/j.niox.2003.12.002Vernet D, Ferrini MG, Valente EG, Magee TR, Bou-Gharios G, Rajfer J, Gonzalez-Cadavid NF. Effect of nitric oxide on the differentiation of fibroblasts into myofibroblasts in the Peyronie's fibrotic plaque and in its rat model. Nitric Oxide. 2002;7(4):262-76. DOI: 10.1016/s1089-8603(02)00124-6Vernet D, Ferrini MG, Valente EG, Magee TR, Bou-Gharios G, Rajfer J, Gonzalez-Cadavid NF. Effect of nitric oxide on the differentiation of fibroblasts into myofibroblasts in the Peyronie's fibrotic plaque and in its rat model. Nitric Oxide. 2002;7(4):262-76. DOI: 10.1016/s1089-8603(02)00124-6Kovanecz I, Rambhatla A, Ferrini M, Vernet D, Sanchez S, Rajfer J, Gonzalez-Cadavid N. Long-term continuous sildenafil treatment ameliorates corporal veno-occlusive dysfunction (CVOD) induced by cavernosal nerve resection in rats. Int J Impot Res. 2008;20(2):202-12. DOI: 10.1038/sj.ijir.3901612Kovanecz I, Rambhatla A, Ferrini M, Vernet D, Sanchez S, Rajfer J, Gonzalez-Cadavid N. Long-term continuous sildenafil treatment ameliorates corporal veno-occlusive dysfunction (CVOD) induced by cavernosal nerve resection in rats. Int J Impot Res. 2008;20(2):202-12. DOI: 10.1038/sj.ijir.3901612Ferrini MG, Kovanecz I, Nolazco G, Rajfer J, Gonzalez-Cadavid NF. Effects of long-term vardenafil treatment on the development of fibrotic plaques in a rat model of Peyronie's disease. BJU Int. 2006;97(3):625-33. DOI: 10.1111/j.1464-410X.2006.05955.xFerrini MG, Kovanecz I, Nolazco G, Rajfer J, Gonzalez-Cadavid NF. Effects of long-term vardenafil treatment on the development of fibrotic plaques in a rat model of Peyronie's disease. BJU Int. 2006;97(3):625-33. DOI: 10.1111/j.1464-410X.2006.05955.xKovanecz I, Rambhatla A, Ferrini MG, Vernet D, Sanchez S, Rajfer J, Gonzalez-Cadavid N. Chronic daily tadalafil prevents the corporal fibrosis and veno-occlusive dysfunction that occurs after cavernosal nerve resection. BJU Int. 2008;101(2):203-10. DOI: 10.1111/j.1464-410X.2007.07223.xKovanecz I, Rambhatla A, Ferrini MG, Vernet D, Sanchez S, Rajfer J, Gonzalez-Cadavid N. Chronic daily tadalafil prevents the corporal fibrosis and veno-occlusive dysfunction that occurs after cavernosal nerve resection. BJU Int. 2008;101(2):203-10. DOI: 10.1111/j.1464-410X.2007.07223.xLevine LA, Greenfield JM, Estrada CR. Erectile dysfunction following surgical correction of Peyronie's disease and a pilot study of the use of sildenafil citrate rehabilitation for postoperative erectile dysfunction. J Sex Med. 2005;2(2):241-7. DOI: 10.1111/j.1743-6109.2005.20234.xLevine LA, Greenfield JM, Estrada CR. Erectile dysfunction following surgical correction of Peyronie's disease and a pilot study of the use of sildenafil citrate rehabilitation for postoperative erectile dysfunction. J Sex Med. 2005;2(2):241-7. DOI: 10.1111/j.1743-6109.2005.20234.xChung E, Deyoung L, Brock GB. The role of PDE5 inhibitors in penile septal scar remodeling: assessment of clinical and radiological outcomes. J Sex Med. 2011;8(5):1472-7. DOI: 10.1111/j.1743-6109.2011.02217.xChung E, Deyoung L, Brock GB. The role of PDE5 inhibitors in penile septal scar remodeling: assessment of clinical and radiological outcomes. J Sex Med. 2011;8(5):1472-7. DOI: 10.1111/j.1743-6109.2011.02217.xSmith WB 2nd, McCaslin IR, Gokce A, Mandava SH, Trost L, Hellstrom WJ. PDE5 inhibitors: considerations for preference and long-term adherence. Int J Clin Pract. 2013;67(8):768-80. DOI: 10.1111/ijcp.12074Smith WB 2nd, McCaslin IR, Gokce A, Mandava SH, Trost L, Hellstrom WJ. PDE5 inhibitors: considerations for preference and long-term adherence. Int J Clin Pract. 2013;67(8):768-80. DOI: 10.1111/ijcp.12074Levine LA. Peyronie's disease and erectile dysfunction: Current understanding and future direction. Indian Journal of Urology. 2006;22:246.Levine LA. Peyronie's disease and erectile dysfunction: Current understanding and future direction. Indian Journal of Urology. 2006;22:246.Yuan J, Hoang AN, Romero CA, Lin H, Dai Y, Wang R. Vacuum therapy in erectile dysfunction--science and clinical evidence. Int J Impot Res. 2010;22(4):211-9. Erratum in: Int J Impot Res. 2010;22(4):290. PMID: 20410903. DOI: 10.1038/ijir.2010.4.Yuan J, Hoang AN, Romero CA, Lin H, Dai Y, Wang R. Vacuum therapy in erectile dysfunction--science and clinical evidence. Int J Impot Res. 2010;22(4):211-9. Erratum in: Int J Impot Res. 2010;22(4):290. PMID: 20410903. DOI: 10.1038/ijir.2010.4.Yang XL, Yang Y, Fu FD, Wu CJ, Qin F, Yuan JH. Optimal pressure in penile rehabilitation with a vacuum erection device: evidence based on a rat model. Asian J Androl. 2019;21(5):516-521. DOI: 10.4103/aja.aja_7_19Yang XL, Yang Y, Fu FD, Wu CJ, Qin F, Yuan JH. Optimal pressure in penile rehabilitation with a vacuum erection device: evidence based on a rat model. Asian J Androl. 2019;21(5):516-521. DOI: 10.4103/aja.aja_7_19Lin HC, Yang WL, Zhang JL, Dai YT, Wang R. Penile rehabilitation with a vacuum erectile device in an animal model is related to an antihypoxic mechanism: blood gas evidence. Asian J Androl. 2013;15(3):387-90. DOI: 10.1038/aja.2013.18Lin HC, Yang WL, Zhang JL, Dai YT, Wang R. Penile rehabilitation with a vacuum erectile device in an animal model is related to an antihypoxic mechanism: blood gas evidence. Asian J Androl. 2013;15(3):387-90. DOI: 10.1038/aja.2013.18Lin H, Wang G, Wang R,. Vacuum erectile device for penile rehabilitation. Journal of Integrative Nephrology and Andrology. 2014;1(1):4-10. DOI: 10.4103/2225-1243.137541Lin H, Wang G, Wang R,. Vacuum erectile device for penile rehabilitation. Journal of Integrative Nephrology and Andrology. 2014;1(1):4-10. DOI: 10.4103/2225-1243.137541Avant RA, Ziegelmann M, Nehra A, Alom M, Kohler T, Trost L. Penile Traction Therapy and Vacuum Erection Devices in Peyronie's Disease. Sex Med Rev. 2019;7(2):338-348. DOI: 10.1016/j.sxmr.2018.02.005Avant RA, Ziegelmann M, Nehra A, Alom M, Kohler T, Trost L. Penile Traction Therapy and Vacuum Erection Devices in Peyronie's Disease. Sex Med Rev. 2019;7(2):338-348. DOI: 10.1016/j.sxmr.2018.02.005Осадчинский А.Е., Павлов И.С., Котов С.В. Пенильная реабилитация у пациентов после радикальной простатэктомии. Экспериментальная и клиническая урология. 2021;14(3):73-79. DOI: 10.29188/2222-8543-2021-14-3-73-79Osadchinskii A.E., Pavlov I.S., Kotov S.V. Penile rehabilitation in patients after radical prostatectomy. Experimental and Clinical Urology. 2021;14(3):73-79. DOI: 10.29188/2222-8543-2021-14-3-73-79Lue TF, El-Sakka AI. Lengthening shortened penis caused by Peyronie's disease using circular venous grafting and daily stretching with a vacuum erection device. J Urol. 1999;161(4):1141-4. PMID: 10081856.Lue TF, El-Sakka AI. Lengthening shortened penis caused by Peyronie's disease using circular venous grafting and daily stretching with a vacuum erection device. J Urol. 1999;161(4):1141-4. PMID: 10081856.Yurkanin JP, Dean R, Wessells H. Effect of incision and saphenous vein grafting for Peyronie's disease on penile length and sexual satisfaction. J Urol. 2001;166(5):1769-72; discussion 1772-3. PMID: 11586221.Yurkanin JP, Dean R, Wessells H. Effect of incision and saphenous vein grafting for Peyronie's disease on penile length and sexual satisfaction. J Urol. 2001;166(5):1769-72; discussion 1772-3. PMID: 11586221.Valenzuela R, Ziegelmann M, Tokar S, Hillelsohn J. The use of penile traction therapy in the management of Peyronie's disease: current evidence and future prospects. Ther Adv Urol. 2019;11:1756287219838139. DOI: 10.1177/1756287219838139Valenzuela R, Ziegelmann M, Tokar S, Hillelsohn J. The use of penile traction therapy in the management of Peyronie's disease: current evidence and future prospects. Ther Adv Urol. 2019;11:1756287219838139. DOI: 10.1177/1756287219838139Mehr J, Santarelli S, Green TP, Beetz J, Panuganti S, Wang R. Emerging Roles of Penile Traction Therapy and Vacuum Erectile Devices. Sex Med Rev. 2022;10(3):421-433. DOI: 10.1016/j.sxmr.2021.12.003Mehr J, Santarelli S, Green TP, Beetz J, Panuganti S, Wang R. Emerging Roles of Penile Traction Therapy and Vacuum Erectile Devices. Sex Med Rev. 2022;10(3):421-433. DOI: 10.1016/j.sxmr.2021.12.003Chung E, De Young L, Solomon M, Brock GB. Peyronie's disease and mechanotransduction: an in vitro analysis of the cellular changes to Peyronie's disease in a cell-culture strain system. J Sex Med. 2013;10(5):1259-67. DOI: 10.1111/jsm.12082Chung E, De Young L, Solomon M, Brock GB. Peyronie's disease and mechanotransduction: an in vitro analysis of the cellular changes to Peyronie's disease in a cell-culture strain system. J Sex Med. 2013;10(5):1259-67. DOI: 10.1111/jsm.12082Usta MF, Ipekci T. Penile traction therapy for Peyronie's disease-what's the evidence? Transl Androl Urol. 2016;5(3):303-9. DOI: 10.21037/tau.2016.03.25Usta MF, Ipekci T. Penile traction therapy for Peyronie's disease-what's the evidence? Transl Androl Urol. 2016;5(3):303-9. DOI: 10.21037/tau.2016.03.25Lin H, Liu C, Wang R. Effect of Penile Traction and Vacuum Erectile Device for Peyronie's Disease in an Animal Model. J Sex Med. 2017;14(10):1270-1276. DOI: 10.1016/j.jsxm.2017.08.011Lin H, Liu C, Wang R. Effect of Penile Traction and Vacuum Erectile Device for Peyronie's Disease in an Animal Model. J Sex Med. 2017;14(10):1270-1276. DOI: 10.1016/j.jsxm.2017.08.011Toussi A, Ziegelmann M, Yang D, Manka M, Frank I, Boorjian SA, Tollefson M, Köhler T, Trost L. Efficacy of a Novel Penile Traction Device in Improving Penile Length and Erectile Function Post Prostatectomy: Results from a Single-Center Randomized, Controlled Trial. J Urol. 2021;206(2):416-426. DOI: 10.1097/JU.0000000000001792Toussi A, Ziegelmann M, Yang D, Manka M, Frank I, Boorjian SA, Tollefson M, Köhler T, Trost L. Efficacy of a Novel Penile Traction Device in Improving Penile Length and Erectile Function Post Prostatectomy: Results from a Single-Center Randomized, Controlled Trial. J Urol. 2021;206(2):416-426. DOI: 10.1097/JU.0000000000001792Moncada-Iribarren I, Jara J, Martinez-Salamanca JI, Cabello R, Hernandez C. Managing Penile Shortening after Peyronie’s Disease Surgery. Journal of Urology. 2007;177(4S):252-252. DOI:10.1016/s0022-5347(18)30990-xMoncada-Iribarren I, Jara J, Martinez-Salamanca JI, Cabello R, Hernandez C. Managing Penile Shortening after Peyronie’s Disease Surgery. Journal of Urology. 2007;177(4S):252-252. DOI:10.1016/s0022-5347(18)30990-xRybak J, Papagiannopoulos D, Levine L. A retrospective comparative study of traction therapy vs. no traction following tunica albuginea plication or partial excision and grafting for Peyronie's disease: measured lengths and patient perceptions. J Sex Med. 2012;9(9):2396-403. DOI: 10.1111/j.1743-6109.2012.02849.xRybak J, Papagiannopoulos D, Levine L. A retrospective comparative study of traction therapy vs. no traction following tunica albuginea plication or partial excision and grafting for Peyronie's disease: measured lengths and patient perceptions. J Sex Med. 2012;9(9):2396-403. DOI: 10.1111/j.1743-6109.2012.02849.xZiegelmann M, Savage J, Toussi A, Alom M, Yang D, Kohler T, Trost L. Outcomes of a Novel Penile Traction Device in Men with Peyronie's Disease: A Randomized, Single-Blind, Controlled Trial. J Urol. 2019;202(3):599-610. DOI: 10.1097/JU.0000000000000245Ziegelmann M, Savage J, Toussi A, Alom M, Yang D, Kohler T, Trost L. Outcomes of a Novel Penile Traction Device in Men with Peyronie's Disease: A Randomized, Single-Blind, Controlled Trial. J Urol. 2019;202(3):599-610. DOI: 10.1097/JU.0000000000000245Porst H. Review of the Current Status of Low Intensity Extracorporeal Shockwave Therapy (Li-ESWT) in Erectile Dysfunction (ED), Peyronie's Disease (PD), and Sexual Rehabilitation After Radical Prostatectomy With Special Focus on Technical Aspects of the Different Marketed ESWT Devices Including Personal Experiences in 350 Patients. Sex Med Rev. 2021;9(1):93-122. DOI: 10.1016/j.sxmr.2020.01.006Porst H. Review of the Current Status of Low Intensity Extracorporeal Shockwave Therapy (Li-ESWT) in Erectile Dysfunction (ED), Peyronie's Disease (PD), and Sexual Rehabilitation After Radical Prostatectomy With Special Focus on Technical Aspects of the Different Marketed ESWT Devices Including Personal Experiences in 350 Patients. Sex Med Rev. 2021;9(1):93-122. DOI: 10.1016/j.sxmr.2020.01.006Jiang P, Christakos A, Fam M, Sadeghi-Nejad H. Prophylactic phenylephrine for iatrogenic priapism: a pilot study with Peyronie's patients. Korean J Urol. 2014;55(10):665-9. DOI: 10.4111/kju.2014.55.10.665Jiang P, Christakos A, Fam M, Sadeghi-Nejad H. Prophylactic phenylephrine for iatrogenic priapism: a pilot study with Peyronie's patients. Korean J Urol. 2014;55(10):665-9. DOI: 10.4111/kju.2014.55.10.665Baird B, Wajswol E, Ericson C, Anderson A, Broderick G. Pre- and Post-Injection Needle Pain in Patients Undergoing First Intracavernosal Injection. J Sex Med. 2022;19(4):590-593. DOI: 10.1016/j.jsxm.2022.01.520Baird B, Wajswol E, Ericson C, Anderson A, Broderick G. Pre- and Post-Injection Needle Pain in Patients Undergoing First Intracavernosal Injection. J Sex Med. 2022;19(4):590-593. DOI: 10.1016/j.jsxm.2022.01.520Elgendi K, Zulia N, Beilan J. A Review on Penile Doppler and Ultrasonography for Erectile Dysfunction. Curr Urol Rep. 2023;24(2):69-74. DOI: 10.1007/s11934-022-01135-4Elgendi K, Zulia N, Beilan J. A Review on Penile Doppler and Ultrasonography for Erectile Dysfunction. Curr Urol Rep. 2023;24(2):69-74. DOI: 10.1007/s11934-022-01135-4Israeli JM, Lokeshwar SD, Efimenko IV, Masterson TA, Ramasamy R. The potential of platelet-rich plasma injections and stem cell therapy for penile rejuvenation. Int J Impot Res. 2022;34(4):375-382. DOI: 10.1038/s41443-021-00482-zIsraeli JM, Lokeshwar SD, Efimenko IV, Masterson TA, Ramasamy R. The potential of platelet-rich plasma injections and stem cell therapy for penile rejuvenation. Int J Impot Res. 2022;34(4):375-382. DOI: 10.1038/s41443-021-00482-zAlkandari MH, Touma N, Carrier S. Platelet-Rich Plasma Injections for Erectile Dysfunction and Peyronie's Disease: A Systematic Review of Evidence. Sex Med Rev. 2022;10(2):341-352. DOI: 10.1016/j.sxmr.2020.12.004Alkandari MH, Touma N, Carrier S. Platelet-Rich Plasma Injections for Erectile Dysfunction and Peyronie's Disease: A Systematic Review of Evidence. Sex Med Rev. 2022;10(2):341-352. DOI: 10.1016/j.sxmr.2020.12.004Sokolakis I, Pyrgidis N, Ziegelmann MJ, Mykoniatis I, Köhler TS, Hatzichristodoulou G. Penile Prosthesis Implantation Combined With Grafting Techniques in Patients With Peyronie's Disease and Erectile Dysfunction: A Systematic Review. Sex Med Rev. 2022;10(3):451-459. DOI: 10.1016/j.sxmr.2021.03.007Sokolakis I, Pyrgidis N, Ziegelmann MJ, Mykoniatis I, Köhler TS, Hatzichristodoulou G. Penile Prosthesis Implantation Combined With Grafting Techniques in Patients With Peyronie's Disease and Erectile Dysfunction: A Systematic Review. Sex Med Rev. 2022;10(3):451-459. DOI: 10.1016/j.sxmr.2021.03.007Levine LA, Becher EF, Bella AJ, Brant WO, Kohler TS, Martinez-Salamanca JI, Trost L, Morey AF. Penile Prosthesis Surgery: Current Recommendations From th e International Consultation on Sexual Medicine. J Sex Med. 2016;13(4):489-518. Erratum in: J Sex Med. 2016;13(7):1145. PMID: 27045255. DOI: 10.1016/j.jsxm.2016.01.017Levine LA, Becher EF, Bella AJ, Brant WO, Kohler TS, Martinez-Salamanca JI, Trost L, Morey AF. Penile Prosthesis Surgery: Current Recommendations From th e International Consultation on Sexual Medicine. J Sex Med. 2016;13(4):489-518. Erratum in: J Sex Med. 2016;13(7):1145. PMID: 27045255. DOI: 10.1016/j.jsxm.2016.01.017

The authors declare that there are no conflicts of interest present.